John-Olov Jansson
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Project grant, The mechanism of clinically used anti-obesity drugs targeting glucagon-like peptide 1 (GLP-1) receptor; an unexpected non-synaptic brain signalling, 2019-01164, 2020–2022, 1 Jan 2020
Project grant, Glucagon-like peptide-1 (GLP-1) suppresses body fat mass via interleukin-6 (IL-6) and IL-1 acting in the brain - how and where?, 2015-02477, 2016–2019, 1 Jan 2016
Sources: openalex.org